Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist

Elizabeth R. Graef, Jean W. Liew, Michael S. Putman, Julia F. Simard, Emily Sirotich, Francis Berenbaum, Alí Duarte-García, Rebecca Grainger, Carly Harrison, Maximilian F. Konig, Peter Korsten, Laurie Proulx, Dawn P. Richards, Philip C. Robinson, Sebastian E. Sattui, Manuel Francisco Ugarte-Gil, Kristen J. Young, Alfred H.J. Kim, Jeffrey A. Sparks

Research output: Contribution to journalReview article

15 Scopus citations
Original languageEnglish
Pages (from-to)S734-S736
JournalAnnals of the Rheumatic Diseases
Volume79
Issue number6
DOIs
StatePublished - Jun 1 2020

Keywords

  • antirheumatic agents
  • health services research
  • hydroxychloroquine

Cite this

Graef, E. R., Liew, J. W., Putman, M. S., Simard, J. F., Sirotich, E., Berenbaum, F., Duarte-García, A., Grainger, R., Harrison, C., Konig, M. F., Korsten, P., Proulx, L., Richards, D. P., Robinson, P. C., Sattui, S. E., Ugarte-Gil, M. F., Young, K. J., Kim, A. H. J., & Sparks, J. A. (2020). Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases, 79(6), S734-S736. https://doi.org/10.1136/annrheumdis-2020-217480